We are live on ! Find out more
Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Portfolio holdings

AUM $44.6B
1-Year Est. Return 28.94%
This Fund
S&P 500
This Quarter Est. Return
+8.3%
1 Year Est. Return
+28.94%
3 Year Est. Return
+82.62%
5 Year Est. Return
+90.41%
10 Year Est. Return
+293.66%
AUM
$36.4B
AUM Growth
+$3.53B
Cap. Flow
+$1.12B
Cap. Flow %
3.08%
Top 10 Hldgs %
20.83%
Holding
3,908
New
299
Increased
2,042
Reduced
1,302
Closed
193

Sector Composition

Rank Sector Weight
1 Technology 12.56%
2 Financials 4.99%
3 Consumer Discretionary 3.69%
4 Communication Services 3.04%
5 Industrials 2.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CTXR icon
3701
Citius Pharmaceuticals
CTXR
$21M
$12K ﹤0.01%
10,044
-173,490
-95% -$242K
RVSNW icon
3702
Rail Vision Ltd Warrant
RVSNW
$721K
$12K ﹤0.01%
112,780
+9,658
+9% +$902
SKYQ
3703
Sky Quarry Inc
SKYQ
$16.4M
$11K ﹤0.01%
2,250
AREB
3704
DELISTED
American Rebel
AREB
0
PSNY icon
3705
Polestar Automotive Holding UK
PSNY
$1.99B
$10K ﹤0.01%
+338
New +$10.8K
NVNO
3706
enVVeno Medical
NVNO
$7.5M
$9K ﹤0.01%
286
MBRX icon
3707
Moleculin Biotech
MBRX
$3.71M
$7K ﹤0.01%
511
PRPH
3708
DELISTED
ProPhase Labs
PRPH
$7K ﹤0.01%
+1,480
New +$5.72K
CNSY
3709
Cerenome, Inc. Common Stock
CNSY
$25.5M
$7K ﹤0.01%
+420
New +$5.16K
UTF.RT
3710
DELISTED
Cohen & Steers Infrastructure Fund Rights exp Oct 16 2025
UTF.RT
$6K ﹤0.01%
+81,281
New +$6.13K
FEMY icon
3711
Femasys
FEMY
$7.1M
$4K ﹤0.01%
+541
New +$7.05K
SCWO icon
3712
374Water
SCWO
$40.6M
$3K ﹤0.01%
1,000
ACXP icon
3713
Acurx Pharmaceuticals
ACXP
$6.62M
-4,250
Closed -$43K
AGGH icon
3714
Simplify Aggregate Bond ETF
AGGH
$604M
-52,008
Closed -$1.07M
AGOX icon
3715
Adaptive Alpha Opportunities ETF
AGOX
$390M
-13,361
Closed -$395K
AIP icon
3716
Arteris
AIP
$1.39B
-21,984
Closed -$210K
ALGN icon
3717
Align Technology
ALGN
$12.4B
-1,566
Closed -$296K
AMED
3718
DELISTED
Amedisys
AMED
-3,101
Closed -$305K
ANSS
3719
DELISTED
Ansys
ANSS
-7,875
Closed -$2.77M
AQMS icon
3720
Aqua Metals
AQMS
$9.56M
-1,571
Closed -$8K
ARIS
3721
DELISTED
Aris Water Solutions
ARIS
-38,729
Closed -$916K
AVMU icon
3722
Avantis Core Municipal Fixed Income ETF
AVMU
$173M
-6,316
Closed -$283K
AVSF icon
3723
Avantis Short-Term Fixed Income ETF
AVSF
$653M
-6,648
Closed -$313K
BCC icon
3724
Boise Cascade
BCC
$2.94B
-2,658
Closed -$231K
BFH icon
3725
Bread Financial
BFH
$4.46B
-6,015
Closed -$344K

Similar funds

Cambridge Investment Research Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Cambridge Investment Research Advisors held 3,908 positions worth $36.4B, up 11% from $32.9B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Cambridge Investment Research Advisors deployed $1.12B of net new capital in Q3 2025, opening 299 new positions and adding to 2,042 existing holdings. Its largest new stake was Scharf ETF: 195,274 shares worth $11M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard FTSE Developed Markets ETF, an estimated $27.2M trimmed.

  • Cambridge Investment Research Advisors's largest Q3 2025 buy was Scharf ETF: 195,274 shares worth $11M.
  • Cambridge Investment Research Advisors added most to Vanguard S&P 500 ETF in Q3 2025, an estimated $67.7M increase.
  • Cambridge Investment Research Advisors's biggest Q3 2025 reduction was Vanguard FTSE Developed Markets ETF, cutting an estimated $27.2M.
  • Cambridge Investment Research Advisors fully exited iShares Large Cap Deep Quarterly Laddered ETF in Q3 2025, selling an estimated $8.43M.
  • Cambridge Investment Research Advisors's ten largest holdings make up 21% of its $36.4B portfolio in Q3 2025.
  • Cambridge Investment Research Advisors opened 299 new positions and closed 193 in Q3 2025.
  • Cambridge Investment Research Advisors's portfolio value rose 11% quarter-over-quarter to $36.4B.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2025, filed 12 Nov 2025.